Summary:
- Imprint Labs, a NYC-based research organization, secured $15M in philanthropic funding to further their work in forensic immunology tools.
- The funding came from backers such as Eric and Wendy Schmidt, Convergent Research, Peter Reinhart, and the NYCEDC.
- Imprint Labs, led by CEO Beck Brachman, focuses on decoding the body’s immune memory to uncover the causes of chronic diseases using experimental and machine learning tools.
Rewritten Article:
Imprint Labs Raises $15M in Funding for Forensic Immunology Research
Imprint Labs, a New York City-based research organization specializing in forensic immunology, recently announced that they have secured $15 million in philanthropic funding to support their groundbreaking work. The funding round saw contributions from notable backers including Eric and Wendy Schmidt, Convergent Research, Peter Reinhart, and the New York City Economic Development Corporation (NYCEDC).
CEO Beck Brachman leads the team at Imprint Labs, where they are dedicated to decoding the body’s immune memory to uncover the hidden causes of chronic diseases. By utilizing experimental and machine learning tools, the company aims to identify and understand the triggers behind various chronic illnesses.
Imprint Labs’ unique approach involves reconstructing immune histories from memory B cells and T cells on a large scale. This innovative “forensic immunology” method allows them to unlock the secrets stored within memory immune cells, providing a comprehensive record of all immune exposures throughout an individual’s life.
Unlike genetic information, which is relatively stable, the immune repertoire is dynamic, sparse, and constantly evolving, presenting a significant challenge in deciphering the data it holds. Imprint Labs’ work is at the forefront of this field, with the ultimate goal of developing new insights into chronic diseases and potential cures.
Incubated by Cornell Tech, Imprint Labs continues to push the boundaries of forensic immunology research, offering hope for a better understanding of complex health issues. The recent funding injection will further accelerate their efforts in unraveling the mysteries of the human immune system.
